MAPK1 and neoplasm: In contrast, ERK still drives TGF-β-induced EMT, converting TGF-β-induced activation of ERK as a mediator of tumor-suppressive TGF-β signals in normal pancreas epithelial cells towards a tumor promoter in the disease state [9].